Skip to content

Koppers

US · KOP #3391 by market cap
43.41 -0.83 -1.88%
Live - 5344 symbols - heartbeat 51s ago · 2026-10-09 19:30

✦ Quant Fair Value how this is computed

Near fair value
8.16 fair value ≈ 35.77 63.37
  • Implied fair-value range of 8.16-63.37, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is +21.4% above the average-multiple fair value of 35.77.

Valuation each multiple against its own 5-year range

P/B ratio 2.14 Expensive vs history 90th percentile
5-year average 1.54 · #33 of 56 in Specialty Chemicals
P/E ratio -9.46 Cheap vs history 4th percentile
5-year average 13.05 · forward 11.27
P/S ratio 0.44 Expensive vs history 84th percentile
5-year average 0.36 · forward 0.42 · #6 of 61 in Specialty Chemicals

Vs. peers Specialty Chemicals

Company Market cap P/E (TTM) P/B Div yield
Koppers (KOP) 820.95M -9.36 2.12 0.78%
Linde (LIN) 222.99B 31.21 5.71 1.28%
Ecolab (ECL) 79.01B 37.83 7.86 1.01%
Sherwin-Williams (SHW) 77.53B 29.46 20.11 1.00%
Air Products & Chemicals (APD) 62.63B -1,339.33 4.51 2.56%
PPG Industries (PPG) 23.11B 14.87 2.74 2.73%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value43.02 Economic moatNone UncertaintyHigh

Trading 0.9% above Morningstar's fair value estimate.

Fair value

Koppers Holdings Inc earns a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a minor 2% premium over our quantitative fair value estimate of $43.02 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating.

The firm's lack of growth undermines our estimated fair value. Stagnant revenue and earnings growth indicates a company's challenges in increasing market share and profitability. Reflecting the firm's growth is its EPS 5-year growth of -4.5%, which sits in the bottom 20% compared with peers globally. On a relative basis, EPS growth has lagged over the last five years, which contributes to our view that shares are expensive.

Conversely, the firm's valuation metrics are reassuring. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's enterprise value to EBITDA ratio of 7.5, for example, falls in the bottom 30% compared with peers globally. Relative to the company's EBITDA, the enterprise value of the business is low, which, despite our unfavorable price/fair value ratio, is a positive attribute.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.

Economic moat

This company lacks a competitive advantage, receiving a quantitative economic moat rating of none. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-10-09 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Koppers discussion 0 comments

Add a comment